Thursday, 25 June 2026


 🏆 Nominations Now Open – Cardiology Awards 2026!

Join the International Research Awards on Cardiology & Cardiovascular Medicine at the 36th Edition of Cardiology Summit, taking place on 28–29 June 2026 in Bangkok, Thailand (Novotel Bangkok Sukhumvit 20).

This prestigious hybrid event (online & in-person) recognizes outstanding contributions from researchers, scientists, academicians, clinicians, healthcare professionals, and industry experts in the field of cardiovascular medicine. Submit your CV and gain global recognition for your achievements, innovations, and research excellence.

🎯 Early Bird Benefit: Avail an exclusive 50% discount on nominations submitted on or before 29 June 2026.

🌐 Domain: cardiology.pencis.com
📢 Channel: Cardiology Awards
🔗 Nomination Link: https://c-i.li/WUcJv

Don't miss this opportunity to showcase your work on an international platform and connect with leading experts from around the world.

#cardiologyawards #cardiologysummit #cardiovascularmedicine #researchawards #medicalresearch #healthcareinnovation #cardiologyconference #scientificresearch #awardnomination #researchers #academicians #medicalscience #bangkok2026 #hybridevent #globalrecognition #cardiology #cardiovascularresearch #healthcareprofessionals #award2026 #earlybirdoffer

Tuesday, 23 June 2026


 🏆 Celebrate Excellence in Cardiology & Cardiovascular Medicine!

Nominations are now open for the Women Researcher Award at the 36th Edition of Cardiology Summit, taking place on 28–29 June 2026 in Bangkok, Thailand 🇹🇭. Recognizing outstanding women researchers with remarkable contributions and publications in cardiovascular science.

🌐 Website: cardiology.pencis.com
📺 YouTube Channel: Pencis Cardiology Awards
📝 Nomination Link: https://c-i.li/WUcJv

#cardiologyawards #womenresearcheraward #cardiology #cardiovascularmedicine #medicalresearch #healthcareinnovation #researchawards #bangkok2026 #womeninscience #cardiologysummit #pencis #globalresearch #medicalconference #hearthealth #scientificexcellence

Friday, 19 June 2026


 Congratulations to Dr. Meryem Beyazal of Ankara Bilkent City Hospital, Turkey, on being nominated for the Research Excellence Award at the International Research Awards on Cardiology & Cardiovascular Medicine!

🌟 Recognized for her valuable contributions to Pediatric Pulmonary Hypertension research, Dr. Beyazal continues to advance knowledge and improve outcomes for children affected by complex cardiovascular conditions.

📚 With 6 scientific publications, 7 citations, and an h-index of 2, this nomination celebrates her dedication to innovation, excellence, and impactful medical research.

👏 Honoring a researcher whose work is helping shape the future of pediatric cardiovascular care and inspiring the next generation of scientific discoveries.

✨ Excellence in research. Commitment to care. Impact that matters.

connect with us " click here "

#Congratulations #ResearchExcellenceAward #CardiologyAwards #CardiovascularMedicine #PediatricPulmonaryHypertension #MedicalResearch #HealthcareInnovation #InternationalResearchAwards #TurkeyResearch #ScientificExcellence #WomenInScience #ResearchImpact #AwardNominee

Tuesday, 16 June 2026


 Congratulations to Prof. Zhengquan Gao of Binzhou Medical University, China, on being nominated for the Best Research Article Award at the International Research Awards on Cardiology & Cardiovascular Medicine!

🌊 With remarkable contributions in the field of Marine Drugs research, Prof. Gao has demonstrated outstanding scientific excellence, reflected by an impressive 2,276 citations, 86 published documents, and an h-index of 28.

👏 This nomination recognizes a distinguished commitment to advancing research, fostering innovation, and creating a lasting impact on global healthcare and biomedical science.

✨ Celebrating research that inspires progress, transforms knowledge into action, and shapes the future of medicine.

#Congratulations #ResearchExcellence #BestResearchArticleAward #InternationalResearchAwards #CardiologyAwards #CardiovascularMedicine #MarineDrugs #ScientificInnovation #ResearchImpact #AcademicAchievement #BinzhouMedicalUniversity #ChinaResearch #GlobalResearch #HealthcareInnovation #MedicalResearch #AwardNominee #ResearchLeadership #FutureOfMedicine

Saturday, 13 June 2026


 Congratulations to Mr. Jubran Al Hooti from University College Dublin, Ireland, on being nominated for the Research Excellence Award at the International Research Awards on Cardiology & Cardiovascular Medicine.

His outstanding research, "A Paradigm Shift in Myocardial Repair," represents a significant contribution to advancing cardiovascular science and innovative therapeutic approaches. We celebrate his dedication to research excellence and impactful scientific achievements.

#researchcellenceaward #cardiologyawards #cardiovascularmedicine #myocardialrepair #medicalresearch #cardiologyresearch #researchinnovation #scientificexcellence #healthcareinnovation #awardnominee #universitycollegedublin #irelandresearch #cardiologyscience #researchachievement #globalresearch #medicalinnovation #hearthealth #cardiovascularresearch #academicexcellence #internationalresearchawards

Monday, 8 June 2026

Atherosclerosis: A Major Cardiovascular Disease

Atherosclerosis is a chronic and progressive disease characterized by the accumulation of fatty deposits, cholesterol, inflammatory cells, and fibrous tissue within the walls of arteries. These deposits, commonly known as plaques, gradually narrow and harden the arteries, reducing blood flow to vital organs and tissues. As one of the leading causes of cardiovascular diseases worldwide, atherosclerosis is responsible for many life-threatening conditions, including coronary artery disease, heart attack, stroke, and peripheral artery disease. Due to its silent progression and widespread prevalence, understanding its causes, mechanisms, risk factors, prevention, and treatment is of great importance.

Pathophysiology of Atherosclerosis

The development of atherosclerosis begins with damage to the inner lining of the artery, known as the endothelium. Factors such as high blood pressure, smoking, elevated cholesterol levels, diabetes, and chronic inflammation can injure the endothelial cells. This damage allows low-density lipoprotein (LDL) cholesterol to penetrate the arterial wall, where it undergoes oxidation.

Oxidized LDL attracts immune cells, particularly macrophages, which engulf the cholesterol and transform into foam cells. The accumulation of foam cells forms fatty streaks, the earliest visible lesions of atherosclerosis. Over time, smooth muscle cells migrate into the affected area and produce fibrous tissue, creating a plaque with a lipid-rich core and a fibrous cap. As plaques enlarge, they narrow the arterial lumen and reduce blood flow. In some cases, plaques rupture, triggering the formation of blood clots that can completely block the artery, resulting in heart attacks or strokes.

Risk Factors

Atherosclerosis develops due to a combination of modifiable and non-modifiable risk factors.

Non-Modifiable Risk Factors

  • Age: The risk increases with advancing age as arterial walls naturally lose elasticity.
  • Gender: Men are generally at higher risk earlier in life, while women's risk rises significantly after menopause.
  • Family History: A genetic predisposition to cardiovascular diseases can increase susceptibility.

Modifiable Risk Factors

  • High LDL Cholesterol and Low HDL Cholesterol: Elevated LDL promotes plaque formation, while HDL helps remove cholesterol from arteries.
  • Hypertension: High blood pressure damages the arterial lining, facilitating plaque development.
  • Smoking: Tobacco toxins cause endothelial dysfunction and promote inflammation.
  • Diabetes Mellitus: High blood glucose levels accelerate vascular damage and plaque progression.
  • Obesity and Sedentary Lifestyle: Lack of physical activity and excess body weight contribute to metabolic abnormalities.
  • Unhealthy Diet: Diets rich in saturated fats, trans fats, refined sugars, and processed foods increase cardiovascular risk.
  • Chronic Stress: Persistent stress may contribute to hypertension and unhealthy lifestyle behaviors.

Clinical Manifestations

Atherosclerosis often remains asymptomatic for many years because plaques develop gradually. Symptoms usually appear only when blood flow becomes significantly restricted or when a plaque ruptures.

The clinical presentation depends on the affected arteries:

  • Coronary Arteries: Chest pain (angina), shortness of breath, and myocardial infarction.
  • Carotid Arteries: Transient ischemic attacks and ischemic stroke.
  • Peripheral Arteries: Leg pain during walking (intermittent claudication), numbness, and poor wound healing.
  • Renal Arteries: High blood pressure and impaired kidney function.

The silent nature of the disease underscores the importance of early detection and preventive measures.

Diagnosis

Several diagnostic methods help identify and assess atherosclerosis. Physicians often begin with a thorough medical history and physical examination, focusing on cardiovascular risk factors.

Common diagnostic tools include:

  • Blood Tests: Measure cholesterol levels, blood glucose, and inflammatory markers.
  • Electrocardiogram (ECG): Detects signs of reduced blood supply to the heart.
  • Echocardiography: Evaluates cardiac structure and function.
  • Ultrasound: Used to assess carotid artery plaques and blood flow.
  • Computed Tomography (CT) Coronary Calcium Scoring: Estimates the extent of arterial calcification.
  • Coronary Angiography: Provides detailed images of coronary artery blockages and remains the gold standard for diagnosis.

Prevention

Since many risk factors are modifiable, atherosclerosis is largely preventable through healthy lifestyle choices. Preventive strategies focus on reducing cardiovascular risk and slowing plaque progression.

A heart-healthy diet rich in fruits, vegetables, whole grains, lean proteins, fish, and unsaturated fats can significantly reduce cholesterol levels. Limiting salt, sugar, and processed foods also helps maintain cardiovascular health.

Regular physical activity, such as at least 150 minutes of moderate aerobic exercise per week, improves blood pressure, cholesterol levels, and body weight. Smoking cessation is one of the most effective measures to reduce cardiovascular risk. Maintaining a healthy body weight and effectively managing diabetes and hypertension are equally important preventive strategies.

Routine health check-ups and screening for cholesterol and blood pressure abnormalities enable early intervention before serious complications occur.

Treatment and Management

The treatment of atherosclerosis aims to prevent disease progression, relieve symptoms, and reduce the risk of complications. Management often involves a combination of lifestyle modifications and pharmacological therapy.

Lifestyle Changes

  • Smoking cessation.
  • Healthy dietary habits.
  • Regular exercise.
  • Weight management.
  • Stress reduction.

Medications

  • Statins: Lower LDL cholesterol and stabilize plaques.
  • Antiplatelet Agents: Aspirin and similar drugs reduce the risk of blood clot formation.
  • Antihypertensive Drugs: Control blood pressure and minimize arterial damage.
  • Glucose-Lowering Medications: Improve glycemic control in diabetic patients.

Interventional Procedures

In severe cases where blood flow is critically reduced, invasive treatments may be necessary. These include:

  • Percutaneous Coronary Intervention (PCI): Balloon angioplasty and stent placement to open blocked arteries.
  • Coronary Artery Bypass Grafting (CABG): Surgical creation of alternative pathways for blood flow around obstructed arteries.

Recent Advances in Research

Recent research has expanded the understanding of atherosclerosis as an inflammatory disease rather than merely a disorder of cholesterol accumulation. Novel therapies targeting inflammatory pathways, such as interleukin-1 inhibitors, have demonstrated potential in reducing cardiovascular events. Advances in imaging technologies and the development of personalized medicine approaches are also improving risk assessment and treatment outcomes. Furthermore, studies investigating the role of genetics, gut microbiota, and artificial intelligence in cardiovascular risk prediction continue to shape the future of atherosclerosis management.

Conclusion

Atherosclerosis remains one of the most significant contributors to global morbidity and mortality. Its gradual and often silent progression makes early detection and prevention essential. By addressing modifiable risk factors through healthy lifestyle choices and appropriate medical management, the burden of this disease can be substantially reduced. Ongoing research continues to provide new insights into its complex mechanisms and offers hope for more effective therapies in the future. Ultimately, a combination of public health initiatives, patient education, and advances in medical science will play a crucial role in combating atherosclerosis and improving cardiovascular health worldwide.





For Enquiries: supportteam@pencis.com


Get Connected here:








Tags : 

Rare Earth Minerals in Cardiology: Advancing Cardiovascular Science and Healthcare

  Introduction Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, accounting for millions of deaths each year. The...